Influence of continuation of beta blockers during dobutamine stress echocardiography for the assessment of myocardial viability in patients with severe ischemic left ventricular dysfunction.

MLA

Poldermans, D., et al. “Influence of Continuation of Beta Blockers during Dobutamine Stress Echocardiography for the Assessment of Myocardial Viability in Patients with Severe Ischemic Left Ventricular Dysfunction.” The American Journal of Cardiology, vol. 88, no. 1, July 2001, p. A7. EBSCOhost, https://doi.org/10.1016/s0002-9149(01)01591-0.

APA

Poldermans, D., Sozzi, F. B., Bax, J. J., Boersma, E., Duncker, D. J., Vourvouri, E., Elhendy, A., Valkema, R., & Roelandt, J. R. (2001). Influence of continuation of beta blockers during dobutamine stress echocardiography for the assessment of myocardial viability in patients with severe ischemic left ventricular dysfunction. The American Journal of Cardiology, 88(1), A7. https://doi.org/10.1016/s0002-9149(01)01591-0

Chicago

Poldermans, D, F B Sozzi, J J Bax, E Boersma, D J Duncker, E Vourvouri, A Elhendy, R Valkema, and J R Roelandt. 2001. “Influence of Continuation of Beta Blockers during Dobutamine Stress Echocardiography for the Assessment of Myocardial Viability in Patients with Severe Ischemic Left Ventricular Dysfunction.” The American Journal of Cardiology 88 (1): A7. doi:10.1016/s0002-9149(01)01591-0.